Eglidine Tablets 2mg (Irsogladine Maleate)
Irsogladine Maleate 2mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.
MFDS item code 202000749 · Approved 2020.02.10
This product's status changed to Approval withdrawn on 2024.02.07. It may no longer be sold, so consult a doctor or pharmacist before taking it.
Treatment of gastric ulcers; improvement of gastric mucosal lesions in acute gastritis and during acute exacerbations of chronic gastritis
This medication is used for the treatment of gastric ulcers and helps improve lesions such as erosion, bleeding, redness, and swelling of the gastric mucosa during acute exacerbations of acute and chronic gastritis. Therefore, it is effective in restoring mucosal damage in the stomach and alleviating symptoms.
1) Gastric ulcer (Adults) Administer 4mg of irsogladine maleate orally once daily. 2) Improvement of gastric mucosal lesions (erosion, bleeding, redness, and edema) in the following conditions: acute gastritis and acute exacerbation of chronic gastritis (Adults) Administer 4mg of irsogladine maleate orally in 1∼2 divided doses daily.
This medicine contains lactose and should not be used by individuals with genetic disorders that affect lactose digestion. During treatment, side effects such as liver dysfunction, constipation, rash, itching, and diarrhea may occur. Rarely, abnormal symptoms such as dizziness, drowsiness, decreased appetite, or changes in blood test values have been reported. Elderly individuals may have decreased bodily functions, therefore, treatment should start with a lower dose while carefully monitoring their condition. Women who are pregnant or may become pregnant should only use this medicine if the benefits outweigh the risks, as safety during pregnancy is not established. Breastfeeding women should avoid this medicine since it may be passed into breast milk, and if it must be taken, nursing should be discontinued. Safety in children has not been sufficiently established, so it should be used with caution in pediatric patients. This medicine should be kept out of reach of children, and care should be taken not to transfer it into other containers, as this may lead to accidents or degradation in quality. The half-life of this medicine in the body is approximately 150 hours, which is relatively long.
Not everyone experiences these, and they can vary from person to person.
This medicine should be stored in a tightly closed container to protect it from air and moisture. It is recommended to maintain a storage temperature between 1 and 30 degrees Celsius to preserve its effectiveness.
White round tablets
Bottle - 30 tablets/bottle, Bottle - 100 tablets/bottle
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Irsogladine Maleate 2mg
Tablet · Prescription medication
Daewoong Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Orally disintegrating Tablet · Prescription medication
Taejun Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Youngjin Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Dong-gu Bio Pharmaceutical Co., Ltd.

Irsogladine Maleate 2mg
Tablet · Prescription medication
Ilyun Pharmaceutical Co., Ltd.

Irsogladine Maleate 4mg
Tablet · Prescription medication
(Co., Ltd.) Nexpharm Korea
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.